The Korean Journal of Medicine10.3904/kjm.2017.92.6.5262017926526-532Effects of Platelet Number and Platelet Indices on Platelet Reactivity in Patients Treated with Clopidogrel or TicagrelorKyeong Ho Yun, Jae Young Cho,,
Journal of Thrombosis and Haemostasis10.1111/j.1538-7836.2011.04419.x2011991730-1737Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responsesR. F. STOREY, K. P. BLIDEN, R. ECOB, A. KARUNAKARAN, K. BUTLER, C. WEI, U. TANTRY, P. A. GURBEL
Journal of Thrombosis and Haemostasis10.1111/jth.120952013112381-384Pretreatment platelet reactivity contribution to residual, post-treatment platelet reactivity in prasugrel-treated and ticagrelor-treated patientsD. Alexopoulos, I. Xanthopoulou, P. Davlouros, G. Tsigkas, A. Damelou, K. C. Theodoropoulos, V. Gkizas, G. Hahalis
British Journal of Anaesthesia10.1093/bja/aet33920141123570-575Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelorE.C. Hansson, C. Shams Hakimi, K. Åström-Olsson, C. Hesse, H. Wallén, M. Dellborg, P. Albertsson, A. Jeppsson,,
Journal of Thrombosis and Haemostasis10.1111/jth.1331020161471484-1485Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: commentN. Tang, S. Y. Yin,,
Journal of Thrombosis and Haemostasis10.1111/jth.1334520161471486-1487Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: replyM. Verdoia, G. De Luca,,
Journal of Thrombosis and Haemostasis10.1111/jth.13511201614122342-2352Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjectsR. Teng, G. F. Carlson, S. Nylander, T. L. G. Andersson,,
Journal of Thrombosis and Haemostasis10.1111/j.1538-7836.2006.02245.x20065182-90Normalization of platelet reactivity in clopidogrel-treated subjectsG. VILAHUR, B. G. CHOI, M. U. ZAFAR, J. F. VILES-GONZALEZ, D. A. VORCHHEIMER, V. FUSTER, J. J. BADIMON
Vascular Pharmacology10.1016/j.vph.2016.05.01020168425-27Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitorsMark R. Thomas, Robert F. Storey,
American Heart Journal10.1016/j.ahj.2012.01.03420121635e31Regarding the “Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study”Dimitrios Alexopoulos,